An Imagable and Photothermal “Abraxane‐Like” Nanodrug for Combination Cancer Therapy to Treat Subcutaneous and Metastatic Breast Tumors
Indocyanine Green
DOI:
10.1002/adma.201404308
Publication Date:
2014-12-12T11:37:05Z
AUTHORS (4)
ABSTRACT
A new "Abraxane-like" nanotheranostic formulation self-assembled from three clinically approved agents, human serum albumin, paclitaxel, and indocyanine green, is developed. Utilizing such a newly formulated nanodrug, combined photothermal chemotherapy conducted under the guidance of imaging, not only effectively eliminating subcutaneous tumors, but also significantly inhibiting development metastatic tumors in this proof-of-concept study. As service to our authors readers, journal provides supporting information supplied by authors. Such materials are peer reviewed may be re-organized for online delivery, copy-edited or typeset. Technical support issues arising (other than missing files) should addressed Please note: The publisher responsible content functionality any Any queries content) directed corresponding author article.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (44)
CITATIONS (397)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....